IPO, Ryan Reynolds and MNTN
BioAge, BKV shares end their first trading day flat after earlier gains
Obesity-drug developer BioAge jumps nearly 30% while Texas-based Barnett Shale driller BKV posts smaller gain.
FierceBiotech1d
BioAge brings in almost $200M from IPO as obesity biotech joins Nasdaq
BioAge Labs is bringing in almost $200 million via its Nasdaq IPO this morning, with the proceeds earmarked for taking its ...
BioAge seeks nearly $200 million in initial public offering
BioAge Labs Inc., which has turned its aging diseases focus toward the hot area of obesity drugs, hopes to raise up to close ...
Obesity drug developer BioAge Labs aims up to $640 mln valuation in upsized US IPO
BioAge Labs is eyeing a valuation of up to $639.7 million in its upsized initial public offering in the United States, the obesity drug developer said on Wednesday, in a sign of strong demand from ...
IPO Roundup: Guardian Pharmacy Services, BKV Corp and more
The U.S. IPO market looks stable this week, with a few new companies aiming to raise capital, as the Federal Reserve reduced ...
Commercial Retail REIT FrontView Seeks $277 Million in IPO
FrontView REIT Inc., a landlord that focuses on businesses with stores in prominent locations, is seeking to raise $277 million in an initial public offering, joining a clutch of companies aiming to ...